D. Healy - Concepedia

Author

D. Healy

Monash University

Also Known As

D Healy, D L Healy, D. Challis, D. HEALY, D. Healy, D. L. HEALY, D. L. Healy, D.L Healy, D.L. HEALY, D.L. Healy

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Monash University Monash Medical Centre Prince of Wales Hospital Royal Women's Hospital Monash Institute of Medical Research

About

D. Healy is an author at Monash University specializing in medicine, obstetrics, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	22	1.2K
2	Public Health	14	14	775
3	Cell Biology	2	2	96
4	Biochemistry	1	1	33
5	Biostatistics	1	1	22

D. Healy

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome Neil McClure, D. Healy, Peter A. W. Rogers, The Lancet Female InfertilityPhysiologyGynecologyOvarian Hyperstimulation SyndromeVascular Biology	1994	375
Circulating Immunoreactive Inhibin Levels During the Normal Human Menstrual Cycle* Robert I. McLachlan, David Robertson, D. Healy, The Journal of Clinical Endocrinology & Metabolism	1987	300
Prevalence and risk factors for obstetric haemorrhage in 6730 singleton births after assisted reproductive technology in Victoria Australia D. Healy, Sue Breheny, Jane Halliday, Human Reproduction	2009	248
Factors affecting low birthweight after assisted reproduction technology: difference between transfer of fresh and cryopreserved embryos suggests an adverse effect of oocyte collection Wen‐Pin Shih, D Rushford, Harold Bourne, Human Reproduction	2008	222
Increased risk of blastogenesis birth defects, arising in the first 4 weeks of pregnancy, after assisted reproductive technologies Jane Halliday, Obioha C. Ukoumunne, H.W.G. Baker, Human Reproduction	2009	189
Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome David J. Amor, Juanjuan Xu, J. Halliday, Human Reproduction	2009	175
The human placenta: A novel source of inhibin R. I. McLachlan, D. Healy, D.M. Robertson, Biochemical and Biophysical Research Communications Human PlacentaDevelopmental BiologyPlacental DevelopmentGynecologyMaternal Health	1986	120
The Stimulation of Prostaglandin Production by Two Antiprogesterone Steroids in Human Endometrial Cells R.W. Kelly, D. Healy, Maureen Cameron, The Journal of Clinical Endocrinology & Metabolism	1986	93
PITUITARY AND ADRENAL RESPONSES TO THE ANTI-PROGESTERONE AND ANTI-GLUCOCORTICOID STEROID RU 486 IN PRIMATES1 D. Healy, G P Chrousos, H M Schulte, The Journal of Clinical Endocrinology & Metabolism In Primates1Adrenal GlandPituitary GlandEndocrine MechanismPrl Secretion	1983	80
THE MATERNAL OVARY IS NOT THE SOURCE OF CIRCULATING INHIBIN LEVELS DURING HUMAN PREGNANCY Robert I. McLachlan, D. Healy, P. Lutjen, Clinical Endocrinology	1987	64

Page 1